昆虫抗菌肽基因工程研究进展

昆虫抗菌肽对细菌、真菌、病毒和原虫都具有杀灭作用 ,甚至对肿瘤细胞也具有杀伤作用。昆虫抗菌肽并且有独特的作用机制 ,成为众多表达系统外源导入基因的侯选对象之一 ,综述了昆虫抗菌肽的种类及其在微生物转基因工程和植物转基因工程中的进展。     

转基因植物作为生物反应器在疫苗生产中的应用

对转基因植物生产口服疫苗的发展、优点与作用机理、方法原理进行介绍,概述当前各种转基因植物疫苗的研究现状,指出了转基因植物疫苗研究面临的问题与前景 。     

转基因植物疫苗的研究进展

利用转基因植物作为生物反应器生产疫苗是一个新兴的技术领域,它具有生产简便、成本低廉,不需要冷藏和低温运输,安全性好,无外源性病原污染等优点。概述当前转基因植物疫苗的研究进展,并就转基因植物疫苗的作用机理及原理方法进行了介绍。     

转基因植物对有机污染物的吸收、转化和降解

有机污染物是土壤、水体和大气环境的重要污染物.利用和加强植物修复作用是控制环境污染的有效途径.近年来,一些具有修复功能的外源基因被陆续引入到植物中,使转基因植物的生物修复能力大大增强.文章介绍了植物对污染环境中有机污染物,尤其是持久性有机污染物(POPs)的吸收、转化和降解作用,阐述了转基因植物用于被污染环境修复方面的研究进展和应用前景.     

植物转基因沉默及控制

植物基因工程的目的就是获取外源基因能够按照设计要求正常表达和稳定遗传的转基因植物。近几年来,广泛报道了转基因植物中存在转基因沉默现象。主要阐述了两种转基因沉默的机理即转录水平的基因沉默和转录后水平的基因沉默,各种机理都涉及DNA DNA,DNA RNA,RNA RNA的相互作用。同时,还讨论一些控制转基因沉默现象的策略,特别是MAR在转基因植物中具有增强基因表达和减少株间差异的作用。     

抗菌肽Cecropin及其在转基因植物抗菌中的应用

Cecropin抗菌肽,又名天蚕素,是一类具有抗菌能力的小分子多肽,热稳定性好,抗菌谱广,在各个应用领域已经得到广泛的研究。本文就Cecropin抗菌肽结构与功能的关系、作用机制和其在转基因植物抗菌领域中的应用进行综述,转基因植物表达Cecropin抗菌肽具有应用优势和实用价值,Cecropin抗菌肽分子结构与作用机制探索的深入能进一步促进转基因植物抗菌研究的发展。     

植物口服疫苗的动物和临床实验*

利用转基因植物生产亚单位疫苗用于口服主动免疫具有安全、廉价和方便等优点。植物可以正确地表达细菌和病毒抗原基因,对动物及人类的临床实验研究表明：食用表达某种抗原的转基因植物可在实验动物或人群体内激起系统免疫和粘膜免疫,产生相应的特异性抗体,这些结果表明了植物口服疫苗的可行性。此外,在治疗自身免疫疾病以及癌症等方面,植物口服疫苗也具有值得关注的作用。     

位点特异性重组系统及其在植物转基因研究中的应用

随着植物转基因研究的不断深入,对基因重组系统提出了新的要求。位点特异性重组系统具有高效、精确等的优点,在植物基因工程领域的应用越来越广泛。对常用的三类位点特异性重组系统的作用机制、优缺点及其应用进展进行了全面的综述,期望为植物转基因研究提供技术参考。对于目前研究较为热点的基因编辑技术CRISPR-Cas系统作了简要概述。     

转基因植物转录后基因沉默的特点、机理及应用

自在转基因植物中发现转基因沉默现象以来 ,很多学者对该现象进行了广泛的研究 ,认为其作用机制有三种 :位置依赖性基因沉默、转录水平基因沉默、转录后水平基因沉默。目前主要集中于转录后水平基因沉默的研究 ,通过研究发现它具有广泛性、可传导性及特异性的特点 ,并对其机制提出了一些假说。最近 ,人们还发现转录后水平基因沉默与植物抗病毒能力有联系。本文对转基因植物转录后基因沉默的特点、机理及应用方面的进展作了综述     

非生物胁迫相关NAC转录因子的结构及功能

NAC是植物特有的一类转录因子,参与植物多个生长发育过程,还参与植物对逆境胁迫的响应。本文对非生物胁迫相关NAC转录因子的结构特征、功能预测、表达特性、在转基因植物中的作用及调控路径进行综述。非生物胁迫相关NAC转录因子具有典型的NAc胁迫亚家族结构特征,根据这些结构特征可以预测其功能;非生物胁迫相关NAc转录因子能响应多种非生物胁迫,其转基因过表达大多能使转基因植物提高一种或几种胁迫耐受性;非生物胁迫相关NAc转录因子有着复杂的调控路径。这些NAc转录因子可用于提高转基因植物的逆境耐受性。     

The production of long chain polyunsaturated fatty acids in transgenic plants by reverse-engineering

The nutritional importance of long chain polyunsaturated fatty acids (LC-PUFAs) is now well-established, with these lipids playing roles in human development and the prevention of various diseases. In particular, n-3 polyunsaturated fatty acids are protective against cardiovascular disease (CVD) and risks associated with metabolic syndrome. In view of the decline in marine fish stocks, which represent the predominant natural reserves of n-3 long chain polyunsaturates, alternative sources are urgently required. One approach may be to express the LC-PUFA-biosynthetic pathway in transgenic plants. Recent progress in validating this approach has now emerged, demonstrating the feasibility of using transgenic plants to synthesise these important human nutrients.     

Biofortification of safflower: an oil seed crop engineered for ALA-targeting better sustainability and plant based omega-3 fatty acids

Alpha-linolenic acid (ALA) deficiency and a skewed n6:n3 fatty acid ratio in the diet is a major explanation for the prevalence of cardiovascular diseases and inflammatory/autoimmune diseases. There is mounting evidence of the health benefits associated with omega-3 long chain polyunsaturated fatty acids (LC PUFA’s). Although present in abundance in fish, a number of factors limit our consumption of fish based omega-3 PUFA’s. To name a few, overexploitation of wild fish stocks has reduced their sustainability due to increased demand of aquaculture for fish oil and meal; the pollution of marine food webs has raised concerns over the ingestion of toxic substances such as heavy metals and dioxins; vegetarians do not consider fish-based sources for supplemental nutrition. Thus alternative sources are being sought and one approach to the sustainable supply of LC-PUFAs is the metabolic engineering of transgenic plants with the capacity to synthesize n3 LC-PUFAs. The present investigation was carried out with the goal of developing transgenic safflower capable of producing pharmaceutically important alpha-linolenic acid (ALA, C18:3, n3). This crop was selected as the seeds accumulate ~?78% of the total fatty acids as linoleic acid (LA, C18:2, n6), the immediate precursor of ALA. In the present work, ALA production was achieved successfully in safflower seeds by transforming safflower hypocotyls with Arabidopsis specific delta 15 desaturase (FAD3) driven by truncated seed specific promoter. Transgenic safflower fortified with ALA is not only potentially valuable nutritional superior novel oil but also has reduced ratio of LA to ALA which is required for good health.     

Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence

The present review aims to illustrate current knowledge about the efficacy of omega-3 long-chain polyunsaturated fatty acids (n?3 LC-PUFAs) in treating/preventing several metabolic pathologies. We reviewed systematically the published evidence on the effectiveness of n?3 LC-PUFAs fish consumption or n?3 LC-PUFAs supplementation on prevention/treatment of obesity, metabolic syndrome, and cardiovascular diseases. Most of the reviewed studies were randomized-controlled interventional trials, although some relevant prospective and cross-sectional studies as well as some meta-analysis were also reviewed. Supplementation with n?3 LC-PUFAs might improve some obesity-associated metabolic syndrome features such as insulin resistance, hypertension and dyslipidemia by decreasing plasma triglycerides. Moreover, the blood pressure-lowering and anti-inflammatory properties of these fatty acids and their benefits in vascular function might confer cardioprotection. However, the efficacy of n?3 LC-PUFA on reducing myocardial infarction, arrhythmia, cardiac and sudden death, or stroke is controversial. Due to the beneficial actions of n?3 LC-PUFAs, several worldwide government and health organizations have established some recommendations of n?3 LC-PUFAs intake for groups of population. In general, the recommended levels for diseases prevention are lower than those advised for particular treatments. However, more clinical trials are necessary to recommend the most effective dosages and formulas (type of n?3 LC-PUFA, EPA/DHA ratio) for specific pathologies.     

Three-Year Breeding Cycle of Rainbow Trout (Oncorhynchus mykiss) Fed a Plant-Based Diet,Totally Free of Marine Resources: Consequences for Reproduction,Fatty Acid Composition and Progeny Survival

Terrestrial plant resources are increasingly used as substitutes for fish meal and fish oil in fish feed in order to reduce the reliance of aquaculture on marine fishery resources. Although many studies have been conducted to assess the effects of such nutritional transition, no whole breeding cycles of fish fed diets free from marine resources has been reported to date. We therefore studied the reproductive performance of trout after a complete cycle of breeding while consuming a diet totally devoid of marine ingredients and thus of n-3 long chain polyunsaturated fatty acids (n-3 LC-PUFAs) that play a major role in the formation of ova. Two groups of female rainbow trout were fed from first feeding either a commercial diet (C, marine and plant ingredients), or a 100% plant-based diet (V, blend of plant proteins and vegetable oils). Livers, viscera, carcasses and ova were sampled at spawning and analyzed for lipids and fatty acids. Although the V-diet was devoid of n-3 LC-PUFAs, significant amounts of EPA and DHA were found in livers and ova, demonstrating efficient bioconversion of linolenic acid and selective orientation towards the ova. Some ova were fertilized to assess the reproductive performance and offspring survival. We observed for the first time that trout fed a 100% plant-based diet over a 3-year breeding cycle were able to produce ova and viable alevins, although the ova were smaller. The survival of offspring from V-fed females was lower (-22%) at first spawning, but not at the second. Our study showed that, in addition to being able to grow on a plant-based diet, rainbow trout reared entirely on such a diet can successfully produce ova in which neo-synthesized n-3 LC-PUFAs are accumulated, leading to viable offspring. However, further adjustment of the feed formula is still needed to optimize reproductive performance.     

Dietary long-chain omega-3 fatty acids of marine origin: a comparison of their protective effects on coronary heart disease and breast cancers

The relationship between high fish consumption and low mortality following coronary heart disease (CHD) and low incidence of breast cancer was first mentioned 3 decades ago. The fishes of interest are rich in omega-3 long-chain polyunsaturated fatty acids (ω-3 LC-PUFAs), especially eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which could be the active nutrients. The current consensus about cardioprotection is that ω-3 LC-PUFAs would mainly exert antiarrhythmic effects. One of the proposed mechanisms is that circulating non-esterified LC-PUFAs partition into cardiac cells membrane phospholipids and exert a direct effect on ionic channels and/or modify intracellular calcium homeostasis. In another hypothesis, changes in the metabolism of phosphoinositides would be involved and lead to the differential activation of PKC isoforms. As compared to the mechanisms proposed for the cardioprotective effects of omega-3 LC-PUFAs, less is known about the molecular mechanisms involved in breast cancers prevention. Some proposed mechanisms such as the modulation of phosphoinositides metabolism and/or modulation of intracellular calcium homeostasis, are common to both pathologies. Other hypotheses involve the alteration of the cellular redox status induced by highly peroxidizable polyunsaturated fatty acids (FA), or the modulation of gene expression, both phenomena being tightly linked to apoptosis. In this review, we report and compare some proposed mechanisms for the involvement of omega-3 LC-PUFAs in both cardiac and breast cancer protection. Deliberately, we chose to discuss only the mechanisms, which are less described in other reviews such as ionic channels in cancer, calcium homeostasis, PKC activation or matrix metalloproteinases in both cancer and cardiac models. The leitmotiv along this review is that cardio- and cancero-protective effects use common pathways. Comparison of the cellular effects might therefore help to highlight the “protective” pathways.     

Genetic adaptation of fatty-acid metabolism: a human-specific haplotype increasing the biosynthesis of long-chain omega-3 and omega-6 fatty acids

Omega-3 and omega-6 long-chain polyunsaturated fatty acids (LC-PUFAs) are essential for the development and function of the human brain. They can be obtained directly from food, e.g., fish, or synthesized from precursor molecules found in vegetable oils. To determine the importance of genetic variability to fatty-acid biosynthesis, we studied FADS1 and FADS2, which encode rate-limiting enzymes for fatty-acid conversion. We performed genome-wide genotyping (n = 5,652 individuals) and targeted resequencing (n = 960 individuals) of the FADS region in five European population cohorts. We also analyzed available genomic data from human populations, archaic hominins, and more distant primates. Our results show that present-day humans have two common FADS haplotypes-defined by 28 closely linked SNPs across 38.9 kb-that differ dramatically in their ability to generate LC-PUFAs. No independent effects on FADS activity were seen for rare SNPs detected by targeted resequencing. The more efficient, evolutionarily derived haplotype appeared after the lineage split leading to modern humans and Neanderthals and shows evidence of positive selection. This human-specific haplotype increases the efficiency of synthesizing essential long-chain fatty acids from precursors and thereby might have provided an advantage in environments with limited access to dietary LC-PUFAs. In the modern world, this haplotype has been associated with lifestyle-related diseases, such as coronary artery disease.     

Adaptive Evolution of the FADS Gene Cluster within Africa

Long chain polyunsaturated fatty acids (LC-PUFAs) are essential for brain structure, development, and function, and adequate dietary quantities of LC-PUFAs are thought to have been necessary for both brain expansion and the increase in brain complexity observed during modern human evolution. Previous studies conducted in largely European populations suggest that humans have limited capacity to synthesize brain LC-PUFAs such as docosahexaenoic acid (DHA) from plant-based medium chain (MC) PUFAs due to limited desaturase activity. Population-based differences in LC-PUFA levels and their product-to-substrate ratios can, in part, be explained by polymorphisms in the fatty acid desaturase (FADS) gene cluster, which have been associated with increased conversion of MC-PUFAs to LC-PUFAs. Here, we show evidence that these high efficiency converter alleles in the FADS gene cluster were likely driven to near fixation in African populations by positive selection ∼85 kya. We hypothesize that selection at FADS variants, which increase LC-PUFA synthesis from plant-based MC-PUFAs, played an important role in allowing African populations obligatorily tethered to marine sources for LC-PUFAs in isolated geographic regions, to rapidly expand throughout the African continent 60–80 kya.     

Biosynthesis of very-long-chain polyunsaturated fatty acids in transgenic oilseeds: constraints on their accumulation

Omega6- and omega3-polyunsaturated C20 fatty acids represent important components of the human diet. A more regular consumption and an accordingly sustainable source of these compounds are highly desirable. In contrast with the very high levels to which industrial fatty acids have to be enriched in plant oils for competitive use as chemical feedstocks, much lower percentages of very-long-chain polyunsaturated fatty acids (VLCPUFA) in edible plant oils would satisfy nutritional requirements. Seed-specific expression in transgenic tobacco (Nicotiana tabacum) and linseed (Linum usitatissimum) of cDNAs encoding fatty acyl-desaturases and elongases, absent from all agronomically important plants, resulted in the very high accumulation of Delta6-desaturated C18 fatty acids and up to 5% of C20 polyunsaturated fatty acids, including arachidonic and eicosapentaenoic acid. Detailed lipid analyses of developing seeds from transgenic plants were interpretated as indicating that, after desaturation on phosphatidylcholine, Delta6-desaturated products are immediately channeled to the triacylglycerols and effectively bypass the acyl-CoA pool. Thus, the lack of available Delta6-desaturated acyl-CoA substrates in the acyl-CoA pool limits the synthesis of elongated C20 fatty acids and disrupts the alternating sequence of lipid-linked desaturations and acyl-CoA dependent elongations. As well as the successful production of VLCPUFA in transgenic oilseeds and the identification of constraints on their accumulation, our results indicate alternative strategies to circumvent this bottleneck.